These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3704313)

  • 21. Pirmenol hydrochloride (CI-845) and reference antiarrhythmic agents: effects on early ventricular arrhythmias after acute coronary artery ligation in anesthetized rats.
    Mertz TE; Kaplan HR
    J Pharmacol Exp Ther; 1982 Nov; 223(2):580-6. PubMed ID: 7131307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antiarrhythmic effect of beta-N-hexamethyleneimino-para-butoxypropiophenone (TG-17), novocainamide and quinidine in cardiac arrhythmias evoked by strophanthin K in cats].
    Ammar EM; Kudrin AN
    Farmakol Toksikol; 1969; 32(5):566-70. PubMed ID: 5364670
    [No Abstract]   [Full Text] [Related]  

  • 23. Ventricular tachycardia.
    Willerson JT; Yurchak PM; DeSanctis RW
    Cardiovasc Clin; 1970; 2(2):69-86. PubMed ID: 4131129
    [No Abstract]   [Full Text] [Related]  

  • 24. Ventricular fibrillation threshold and myocardial cyclic AMP production in rats sensitive or resistant to isoproterenol.
    Joseph X; Jordan AW; Balazs T
    Res Commun Chem Pathol Pharmacol; 1984 May; 44(2):239-49. PubMed ID: 6330819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bretylium tosylate in the management of recurrent ventricular fibrillation complicating acute myocardial infarction.
    Dhurandhar RW; Pickron J; Goldman AM
    Heart Lung; 1980; 9(2):265-70. PubMed ID: 6898604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevention of arrhythmia in rats by puhuang].
    Zheng RX; Fang SM; Li ZM; Zhang XM
    Zhongguo Zhong Yao Za Zhi; 1993 Feb; 18(2):108-10, 127. PubMed ID: 8323694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac arrhythmias. Rationale of drug therapy.
    Chung EK
    Singapore Med J; 1973 Sep; 14(3):325-33. PubMed ID: 4591402
    [No Abstract]   [Full Text] [Related]  

  • 28. A cardiac antiarrhythmic screening test using the isolated ischaemic perfused rat heart preparation.
    Lee AY; Zhan CY; Mok CP; Wong TM
    Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):217-22. PubMed ID: 4062438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Value of calcium channel blockers in the prevention of ventricular fibrillation of ischemic etiology: experimental arguments].
    Timour Q; Freysz M; Aupetit JF; Loufoua J; Frassati D; Faucon G
    Bull Acad Natl Med; 1996 Jan; 180(1):215-26; discussion 226-7. PubMed ID: 8696877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between the prolonged QTc interval and ventricular fibrillation.
    Johnson CT; Cowan M
    Heart Lung; 1986 Mar; 15(2):141-50. PubMed ID: 3633244
    [No Abstract]   [Full Text] [Related]  

  • 31. Is all ventricular fibrillation the same? A comparison of ischemically induced with electrically induced ventricular fibrillation in a porcine cardiac arrest and resuscitation model.
    Niemann JT; Rosborough JP; Youngquist S; Thomas J; Lewis RJ
    Crit Care Med; 2007 May; 35(5):1356-61. PubMed ID: 17414084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ventricular fibrillation in chronic heart disease].
    Pleskot M; Parízek P; Hodac M; Haman L; Stásek J; Cervinka P; Tauchman M
    Vnitr Lek; 2000 Feb; 46(2):80-6. PubMed ID: 11048528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Medical treatment of extrasystole and tachycardia (author's transl)].
    Theisen K; Jahrmärker H
    MMW Munch Med Wochenschr; 1980 Jan; 122(3):87-94. PubMed ID: 6154235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental effects of anti-arrhythmic drugs on ventricular fibrillation thresholds altered by regional hyperkalemia.
    Logic JR
    Arch Int Pharmacodyn Ther; 1973 Aug; 204(2):268-74. PubMed ID: 4748780
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of low-dose quinidine on ventricular tachyarrhythmias in patients with Brugada syndrome: low-dose quinidine therapy as an adjunctive treatment.
    Mizusawa Y; Sakurada H; Nishizaki M; Hiraoka M
    J Cardiovasc Pharmacol; 2006 Mar; 47(3):359-64. PubMed ID: 16633076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of quinidine in high-risk patients with Brugada syndrome.
    Belhassen B; Glick A; Viskin S
    Circulation; 2004 Sep; 110(13):1731-7. PubMed ID: 15381640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The treatment of cardiac arrhythmias: complexity and schematization].
    Chatillon J
    Rev Med Suisse Romande; 1973 Jan; 93(1):19-36. PubMed ID: 4145983
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antiarrhythmic agents. Are they able to prevent sudden death?].
    Tidsskr Nor Laegeforen; 1971 Sep; 91(25):1824-6. PubMed ID: 4106718
    [No Abstract]   [Full Text] [Related]  

  • 39. Antiarrhythmic potency of naloxone determined by a screening test using the isolated ischaemic perfused rat heart preparation.
    Lee AY; Wong TM
    Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):212-5. PubMed ID: 3592865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The actions and clinical use of the newer antiarrhythmic drugs.
    Hayes AH
    Ration Drug Ther; 1972 Jul; 6(7):1-6. PubMed ID: 5085124
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.